Overview

Evaluation of Naltrexone as a Treatment for Self-injurious Behavior

Status:
Withdrawn
Trial end date:
2017-01-04
Target enrollment:
Participant gender:
Summary
The proposed study examines the effect of oral naltrexone on self-injurious behavior (SIB) in adolescents and adults of normal intelligence.
Phase:
Phase 4
Details
Lead Sponsor:
Western Michigan University School of Medicine
Collaborator:
Kalamazoo Community Foundation
Treatments:
Naltrexone